Companies 0 See All

Hedge Funds 0 See All

Insiders 0 See All

Institutional Investors 0 See All

Click here to see all results for

Home > Insider Trading > Filing (0000921895-20-002868)

Filing Details

Accession Number:: 0000921895-20-002868
Form Type:: 4
Zero Holdings:: No
Publication Time:: 2020-11-10 16:25:10
Reporting Period:: 2020-11-06

Accepted Time:: 2020-11-10 16:25:10
SEC Url:: Form 4 Filing

Issuer

Cik	Name	Symbol	Sector (SIC)	IRS No
1599298	Summit Therapeutics Inc.	SMMT	()	4

Insiders

Cik	Name	Reported Address	Insider Title	Director	Officer	Large Shareholder	Other
1055919	W Robert Duggan	611 South Fort Harrison Ave Suite 306 Clearwater FL 33756	Chief Executive Officer	Yes	Yes	Yes	No

Reported Non-Derivative Transactions

Show Other Fields >>

Sec. Name	Acquisiton - Disposition	Date	Amount	Price	Remaning Holdings	Equity Swap Involved	Form Type	Code	Nature of Ownership	Explanation
Common Stock	Acquisiton	2020-11-06	14,071,856	$3.34	56,296,533	No	4	P	Direct

Equity Swap Involved	Form Type	Code	Nature of Ownership	Explanation
No	4	P	Direct

Footnotes

Represents the number of shares of Common Stock that the Reporting Person purchased in a private placement at a price of $3.34 per share pursuant to a Securities Purchase Agreement, dated October 2, 2020, by and between the Reporting Person and the Issuer (the "Purchase Agreement"). Pursuant to the Purchase Agreement, the Issuer directed the Reporting Person to purchase 14,071,856 shares of Common Stock.